Clinical trial
B-type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL)…
NCT00130611 · University Hospital, Basel, Switzerland, Other · Completed
Key facts
| NCT number | NCT00130611 |
|---|---|
| Title | B-type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice |
| Official title | B-type Natriuretic Peptide for Acute Shortness of Breath EvaLuation (BASEL) Study - Private Practice |
| Lead sponsor | University Hospital, Basel, Switzerland, Other |
| Collaborators | Swiss National Science Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Dyspnea |
| Intervention type | Other |
| Interventions | BNP measurement, Clinical examination |
| Enrollment | 250 |
| Start date | Jan 1, 2004 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2011 |
| First posted | Aug 15, 2005 |
| Last update posted | May 29, 2013 |
| Countries | Germany, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: